**Core Concept**
Renal vascular hypertension refers to the elevation of blood pressure caused by a reduction in renal blood flow, often due to stenosis or occlusion of the renal arteries. This condition is characterized by a decrease in the glomerular filtration rate (GFR) and an increase in renin release, leading to vasoconstriction and fluid retention.

**Why the Correct Answer is Right**
The correct answer involves the renin-angiotensin-aldosterone system (RAAS). In renal vascular hypertension, the decreased blood flow to the kidneys stimulates the release of renin from the juxtaglomerular cells. Renin then triggers a cascade of reactions, resulting in the formation of angiotensin II, a potent vasoconstrictor that increases blood pressure. Additionally, angiotensin II stimulates the secretion of aldosterone from the adrenal cortex, leading to sodium retention and further increases in blood pressure.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not directly related to the pathophysiology of renal vascular hypertension.
* **Option B:** This option may be related to other types of hypertension, such as primary aldosteronism, but it is not the correct answer for renal vascular hypertension.
* **Option D:** This option may be related to the treatment of hypertension, but it is not the correct answer for the underlying pathophysiology of renal vascular hypertension.

**Clinical Pearl / High-Yield Fact**
In patients with renal vascular hypertension, the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) can help to reduce blood pressure by blocking the effects of angiotensin II and reducing sodium retention.

**Correct Answer: A. Renin release stimulates the RAAS, leading to vasoconstriction and fluid retention.**